GET THE APP

Comparison of Once-Daily Triple Therapy versus Conventional Triple Therapy for Patient Compliance and the Eradication of Helicobacter pylori Infection | Abstract
Logo

International Journal of Medical Research & Health Sciences (IJMRHS)
ISSN: 2319-5886 Indexed in: ESCI (Thomson Reuters)

Abstract

Comparison of Once-Daily Triple Therapy versus Conventional Triple Therapy for Patient Compliance and the Eradication of Helicobacter pylori Infection

Author(s):Naila Mohiuddin*, Sumaiya Al Hajree, Ruqiya Fatima, Mohammed Mustaneer Akmal, Syed Ibrahim Hassan, Asif Rasheed and Aleem Ahmed Khan

Aim: To compare the effectiveness of once-daily triple therapy with conventional triple therapy for the eradication of H. pylori. Materials and methods: A prospective comparative study in the gastroenterology unit of a tertiary care hospital was conducted for 6 months. 180 patients with active peptic disease tested positive for rapid urease test or 13C-UBT and concomitantly positive for anti-H. pylori antibodies IgG and IgM were given either once-daily (Tinidazole 1000 mg+Azithromycin 500 mg+Rabeprazole 40 mg) or twice-daily (Amoxicillin 500 mg+Clarithromycin 500 mg+Esomeprazole 40 mg) first-line therapy for ten days. Ten weeks after the completion of therapy rapid urease test and 13C-UBT were repeated. Adherence and adverse events were evaluated using pill count, structured questionnaires, and exit interviews. Results: The patient compliance was found to be better in the once-daily group (84.8%) when compared to the twice-daily group (68.8%). However, after treatment with the once-daily regimen, 74.6% of the subjects were tested negative for H. pylori and showed symptomatic relief. Whereas, with the conventional regimen, 68.7% of the subjects were tested negative for RUT and showed symptomatic relief (p=0.4063). Conclusion: We found that there was no significant difference in the eradication rates between both regimens. However, the once-daily regimen resulted in better medication compliance than the conventional regimen, suggesting that it can be considered as a safe and well-tolerated alternative to conventional triple therapies, especially for non-compliant patient groups. Further studies should be performed to confirm the results.


Archive
Scope Categories
  • Clinical Research
  • Epidemiology
  • Oncology
  • Biomedicine
  • Dentistry
  • Medical Education
  • Physiotherapy
  • Pulmonology
  • Nephrology
  • Gynaecology
  • Dermatology
  • Dermatoepidemiology
  • Otorhinolaryngology
  • Ophthalmology
  • Sexology
  • Osteology
  • Kinesiology
  • Neuroscience
  • Haematology
  • Psychology
  • Paediatrics
  • Angiology/Vascular Medicine
  • Critical care Medicine
  • Cardiology
  • Endocrinology
  • Gastroenterology
  • Infectious Diseases and Vaccinology
  • Hepatology
  • Geriatric Medicine
  • Bariatrics
  • Pharmacy and Nursing
  • Pharmacognosy and Phytochemistry
  • Radiobiology
  • Pharmacology
  • Toxicology
  • Clinical immunology
  • Clinical and Hospital Pharmacy
  • Cell Biology
  • Genomics and Proteomics
  • Pharmacogenomics
  • Bioinformatics and Biotechnology
  • Google Scholar citation report
    Citations : 2979

    International Journal of Medical Research & Health Sciences received 2979 citations as per google scholar report

    International Journal of Medical Research & Health Sciences peer review process verified at publons